| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/03/2008 | WO2008079102A1 Modified release loxoprofen compositions |
| 07/03/2008 | WO2008079101A2 Oral composition for improving mouth environment |
| 07/03/2008 | WO2008078922A1 Revaprazan-containing solid dispersion and process for the preparation thereof |
| 07/03/2008 | WO2008078842A1 Ciclesonide containing sterile aqueous suspension |
| 07/03/2008 | WO2008078730A1 Preparation for transnasal application |
| 07/03/2008 | WO2008078729A1 Method for improving dissolution property |
| 07/03/2008 | WO2008078728A1 Ascorbic acid-containing pharmaceutical composition |
| 07/03/2008 | WO2008078727A1 Pharmaceutical composition having improved dissolution property |
| 07/03/2008 | WO2008078726A1 Solid preparation |
| 07/03/2008 | WO2008078423A1 Composition containing plant sterol and phosphatidylcholine and process for producing the same |
| 07/03/2008 | WO2008078341A2 Stable pharmaceutical formulations of atorvastatin magnesium salt |
| 07/03/2008 | WO2008078189A2 Factor vii and viia compositions |
| 07/03/2008 | WO2008078102A2 Lipids and their use as non-viral delivery vehicle |
| 07/03/2008 | WO2008078076A1 Morpholino compound microemulsion |
| 07/03/2008 | WO2008078071A1 Medicaments and methods comprising a compound that promotes oestrogenic activity for wound healing |
| 07/03/2008 | WO2008077939A2 Duloxetine composition |
| 07/03/2008 | WO2008077823A1 Self-microemulsifying drug delivery systems |
| 07/03/2008 | WO2008077813A2 Orally disintegrating tablets |
| 07/03/2008 | WO2008077712A1 Gel useful for the delivery of ophthalmic drugs |
| 07/03/2008 | WO2008077641A1 Nanoemulsion |
| 07/03/2008 | WO2008077614A2 Use of a composition made of mineral nutrients and optionally acetogenic and/or butyrogenic bacteria in order to avoid or reduce the formation of gas in the large intestine of a mammal and the resulting abdominal problems |
| 07/03/2008 | WO2008077591A2 Pharmaceutical formulation comprising neurokinin antagonist |
| 07/03/2008 | WO2008077481A2 Material depot for releasing an antibacterial active agent |
| 07/03/2008 | WO2008077402A1 Microcapsules |
| 07/03/2008 | WO2008077401A1 Reactive powdering |
| 07/03/2008 | WO2008077277A1 Process for preparation of spider lyophilizate and use in medicaments and functional foods |
| 07/03/2008 | WO2008077276A1 An injectable solution of spider venom and preparation thereof |
| 07/03/2008 | WO2008077248A1 Coatings for implantable medical devices for liposome delivery |
| 07/03/2008 | WO2008077247A1 Coatings for implantable medical devices comprising cholesterol |
| 07/03/2008 | WO2008077236A1 Adp-ribosyl transferase fusion variant proteins |
| 07/03/2008 | WO2008057442A3 Eyelid scrub composition |
| 07/03/2008 | WO2008051186A3 Nanoemulsion containing compositions having ant i -inflammatory activity |
| 07/03/2008 | WO2008049401A3 Nail varnish for cosmetic and medical applications |
| 07/03/2008 | WO2008042619A3 Self-preserved aqueous pharmaceutical compositions |
| 07/03/2008 | WO2008039406A3 Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist |
| 07/03/2008 | WO2008037557A3 Rapidly solubilising formulation of non-steroidal anti-inflammatory drugs |
| 07/03/2008 | WO2008036855A3 Self-preserved aqueous pharmaceutical compositions |
| 07/03/2008 | WO2008030209A3 Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor |
| 07/03/2008 | WO2007149868A3 Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles |
| 07/03/2008 | WO2007146683A3 Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester |
| 07/03/2008 | WO2007137131A8 Delivery of active agents using a chocolate vehicle |
| 07/03/2008 | WO2007127272A3 Method of producing immunoliposomes and compositions thereof |
| 07/03/2008 | WO2007117469A3 Compositions of less immunogenic and long-circulating protein-lipid complexes |
| 07/03/2008 | WO2007111720A8 Formulation of insoluble small molecule therapeutics in lipid-based carriers |
| 07/03/2008 | WO2007052003A9 Sealed tablet |
| 07/03/2008 | US20080161907 Stent coated with a sustained-release drug delivery and method for use thereof |
| 07/03/2008 | US20080161759 Device and Method for Delivering or Withdrawing a Substance through the Skin |
| 07/03/2008 | US20080161562 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile |
| 07/03/2008 | US20080161492 Two-phase, water-absorbent bioadhesive composition |
| 07/03/2008 | US20080161418 Oils prepared by Kolbe electrolysis of fatty acids |
| 07/03/2008 | US20080161417 Xylitol Granules Capable of Directly Being Compressible Into Tablets and Preparation Process Thereof |
| 07/03/2008 | US20080161411 Methods and compositions for treating pulmonary disorders using optically pure (r,r)-formoterol |
| 07/03/2008 | US20080161406 Novel formulations of alpha-2,4-disulfophenyl-N-tert-butylnitrone |
| 07/03/2008 | US20080161382 Suspensions of docetaxel particles with protein or polymer stabilizing agent; shorter administration times; reducing toxicity and hypersensitivity side effects |
| 07/03/2008 | US20080161376 Using antimycotic formulation containing propylene glycol, disodium edta, mineral oil, polyglyceryl-3-oleate, glyceryl monoisostearate, microcrystalline wax, silicon dioxide, methylparaben, propylparaben, butoconazole nitrate in water and sorbitol solution |
| 07/03/2008 | US20080161357 Devices and methods for pain management |
| 07/03/2008 | US20080161356 Precise, long duration; metered systemic delivery of sufentanil; minimizing tissue trauma; reducing gastrointestinal and respiratory system side effects |
| 07/03/2008 | US20080161250 Topical treatment or prevention of ocular infections |
| 07/03/2008 | US20080160098 Use of simple amino acids to form porous particles |
| 07/03/2008 | US20080160097 Can be more effectively formulated as a water-in-oil, water-in-silicon, or water-in-wax emulsion and be less irritating to end users |
| 07/03/2008 | US20080160096 Non-immunogenic biocompatible and biodegradable stimuli-sensitive polymeric nanoparticles; for targeting drugs to tissue or cells; self-assembling; gene therapy; encapsulating nucleic acid such as therapeutic DNA, RNA, siRNA, antisense oligonucleotides |
| 07/03/2008 | US20080160095 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 07/03/2008 | US20080160094 Comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein; brain disorders; kits; efficiently target and deliver substances |
| 07/03/2008 | US20080160093 Composition comprising particulate zinc materials having a defined crystallite size |
| 07/03/2008 | US20080160092 Use of simple amino acids to form porous particles |
| 07/03/2008 | US20080160091 Composite materials comprised of calcium compounds and protein components |
| 07/03/2008 | US20080160090 Laser-Activated Nanothermolysis of Cells |
| 07/03/2008 | US20080160089 Vaccine delivery compositions and methods of use |
| 07/03/2008 | US20080160088 Used for preventing and/or reducing the embrittlement of the skin and/or semi-mucous membranes and/or for protecting the skin and/or semi-mucous membranes against water loss and/or external attack; comprises calcium salt preferably calcium pantetheine sulfonate |
| 07/03/2008 | US20080160087 Gel preparation for oral administration |
| 07/03/2008 | US20080160086 Comprising an ingestible matrix within which a calcium source is substantially uniformly and completely dispersed; for preventing bone loss; aid in the uptake and/or metabolism of calcium by the body |
| 07/03/2008 | US20080160085 Cell delivery matrices |
| 07/03/2008 | US20080160083 Composition and method for treatment of premenstrual symptoms |
| 07/03/2008 | US20080160082 Controlled release compositions comprising Nimesulide |
| 07/03/2008 | US20080160081 Release-retarding matrix comprising about 40 to about 80% (by weight) hydroxypropyl methyl cellulose with a maximum apparent viscosity of about 5600 cP; benign prostatic hyperplasia, lower urinary tract symptoms, female sexual dysfunction, premature ejaculation, and primary dysmenorrheal |
| 07/03/2008 | US20080160080 comprising 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide and a stabilizing polymer; prepared by dissolving drug and stabilizing polymer in a solvent to form a feed solution and then spray drying the feed solution to form amorphous solid dispersion as a powder |
| 07/03/2008 | US20080160079 capsule medication administration system includes: a first capsule for internal body marking; a second capsule for medication; a marking device which makes a marking within a living body; a drug retention section which retains a drug; a release device which releases the drug; a detection device |
| 07/03/2008 | US20080160078 Nanoparticles for drug delivery |
| 07/03/2008 | US20080160077 bioactive lipophilic molecules, such as Coenzyme Q10 (CoQ10) and its reduced analogs (ubiquinols); increased bioavailability |
| 07/03/2008 | US20080160076 consist of water-insoluble hydrophobic synthetic materials which do not significantly affect the pharmaceutical quality of the contents themselves, but improve usability of filled capsules with regard to function, longevity, and/or the geographic location of their use |
| 07/03/2008 | US20080160075 Pharmaceutical Composition Made From Chinese Traditional Medicine And Method Of Producing Thereof |
| 07/03/2008 | US20080160074 three-dimensional synthetic and semi-synthetic compositions having biological activity, such as liposomes, beads or similar particles; anti-inflammatory, organ protective and immune regulatory effects |
| 07/03/2008 | US20080160073 preparations of insulin and glucagon; for use when glucagon response to acute hypoglycemia is impaired or lost in patients with advanced Type 1 and Type 2 diabetes |
| 07/03/2008 | US20080160072 Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| 07/03/2008 | US20080160071 Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| 07/03/2008 | US20080160070 fabric backing and a skin-adhesive polymer matrix; compound diffuses from the matrix through the stratum corneum layer of the user's skin, through the dermis layer of the skin, and into the user's bloodstream |
| 07/03/2008 | US20080160069 extracellular matrix seeded with tumor cells from an individual and a fibrin backing; to screen for anti-tumor compounds; dermal patch stimulates the immune system of a cancer patient to mount an immune response against tumor cells |
| 07/03/2008 | US20080160068 Method for a Medicinal Combination Treatment, and Medicament Combinations Suitable Therefor |
| 07/03/2008 | US20080160067 high bioavailability; comprising an antibiotic, a hydrophobic material, soy protein fines, a disintegrant, a solvent, and optionally a flavor |
| 07/03/2008 | US20080160066 lecithin-DHA-type phospholipid; treating or preventing respiratory failure |
| 07/03/2008 | US20080160065 insert suitable for mammalian intravaginal, buccal, or intrarectal use; non-degradable hydrogel matrix |
| 07/03/2008 | US20080160063 particles or coils or stents coated with platelet binding agents are directed to target vasculature, such as the vasculature of solid tumor masses or AV-malformations or aneurysms or endoleaks |
| 07/03/2008 | US20080160060 administering locally a therapeutic amount of a Sost/Wise antagonist in conjunction with an osteoconductive biocompatible calcium salt scaffold; medical orthopedic or periodontal device; prevents kidney damage |
| 07/03/2008 | US20080160058 bait and uses thereof |
| 07/03/2008 | US20080160056 Oral and Personal Care Compositions and Methods |
| 07/03/2008 | US20080160051 Hemostatic substance with a coating |
| 07/03/2008 | US20080160048 Comprising chimeric cytomegalo virus related promoter sequence and cloning site for insertion of coding sequence in operable linkage; particle mediated gene therapy and immunization |
| 07/03/2008 | US20080160047 Oil in water emulsions containing saponins |
| 07/03/2008 | US20080160006 Nutrient broth for maintenance of brain or spinal cord tissue |
| 07/03/2008 | US20080159987 Using bifidobacteria expressing rifamycin based non-sytemic antibiotic to treat nervous system disorders; probiotics |